Free tool
Stocks listed on Stockholm
We cover 158 companies listed on Stockholm. The median market value in the group is $19.97M. Across the group, the median move over the past trading day is +0.31%. 45% of the 157 with a 200-day average trade above it. Price change over the past year runs from −76.0% to +38.8% across the middle 80 percent of the group, with a median of −24.1%. Across the group, 2 companies currently carry a tier A volume signal.
Other lists in this group
Table
158 of 928 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return |
|---|---|---|---|---|---|
| SOBI.ST | Swedish Orphan Biovitrum AB (publ) | 469.60 SEK | −0.76% | +42.13% | +61.26% |
| GETI-B.ST | Getinge AB (publ) | 243.30 SEK | +2.18% | +14.56% | +20.89% |
| SECT-B.ST | Sectra AB (publ) | 276.20 SEK | −2.47% | +15.28% | −17.02% |
| MCOV-B.ST | Medicover AB (publ) | 243.50 SEK | +8.22% | +14.97% | −8.20% |
| CAMX.ST | Camurus AB (publ) | 615.00 SEK | −1.68% | +0.49% | −15.35% |
| BIOA-B.ST | BioArctic AB (publ) | 345.00 SEK | +6.35% | +11.66% | +12.31% |
| ASKER.ST | Asker Healthcare Group AB (publ) | 74.70 SEK | −7.15% | −8.74% | −24.65% |
| EKTA-B.ST | Elekta AB (publ) | 56.05 SEK | +14.95% | +0.87% | +26.10% |
| ALIF-B.ST | AddLife AB (publ) | 162.30 SEK | +0.87% | +8.17% | −7.20% |
| VIMIAN.ST | Vimian Group AB (publ) | 35.35 SEK | +1.58% | +15.22% | +12.01% |
| ATT.ST | Attendo AB (publ) | 117.90 SEK | +7.57% | +49.22% | +80.74% |
| ALVO-SDB.ST | Alvotech | 46.45 SEK | +33.67% | +1.57% | −39.57% |
| BONEX.ST | Bonesupport Holding AB (publ) | 224.40 SEK | +1.54% | +26.07% | −28.26% |
| NOLA-B.ST | Nolato AB (publ) | 51.80 SEK | +6.91% | −10.27% | −7.00% |
| AMBEA.ST | Ambea AB (publ) | 173.60 SEK | +21.74% | +27.37% | +38.66% |
| VITR.ST | Vitrolife AB (publ) | 95.10 SEK | +9.31% | −27.76% | −30.23% |
| BIOG-B.ST | BioGaia AB (publ) | 117.10 SEK | +1.39% | +15.05% | +13.96% |
| XVIVO.ST | Xvivo Perfusion AB (publ) | 278.80 SEK | +9.08% | +53.95% | +59.31% |
| SYNSAM.ST | Synsam AB (publ) | 59.50 SEK | +5.50% | −7.98% | +5.66% |
| MCAP.ST | MedCap AB (publ) | 554.50 SEK | +3.64% | +4.03% | −10.28% |
| DYVOX.ST | Dynavox Group AB (publ) | 76.70 SEK | +4.14% | −21.71% | −39.29% |
| APOTEA.ST | Apotea AB (publ) | 75.30 SEK | +1.41% | −16.05% | −26.38% |
| ARJO-B.ST | Arjo AB (publ) | 28.38 SEK | +4.11% | −6.88% | −15.25% |
| RAY-B.ST | RaySearch Laboratories AB (publ) | 181.70 SEK | +3.06% | −15.47% | −29.98% |
| HNSA.ST | Hansa Biopharma AB (publ) | 43.30 SEK | +19.22% | +32.42% | +35.65% |
| CEVI.ST | CellaVision AB (publ) | 164.00 SEK | +7.47% | +10.88% | −5.28% |
| EGTX.ST | Egetis Therapeutics AB (publ) | 7.87 SEK | +25.72% | +52.22% | +51.35% |
| HUM.ST | Humana AB (publ) | 71.70 SEK | +14.72% | +46.12% | +81.84% |
| VICO.ST | Vicore Pharma Holding AB (publ) | 10.74 SEK | −0.74% | −2.19% | −1.29% |
| SUS.ST | Surgical Science Sweden AB (publ) | 50.85 SEK | +49.82% | +63.82% | −48.69% |
| STIL.ST | Stille AB | 225.00 SEK | −5.06% | +16.58% | −4.26% |
| CARA.ST | Carasent AB (publ) | 25.25 SEK | +1.00% | −5.78% | −10.62% |
| FLERIE.ST | Flerie AB (publ) | 19.25 SEK | −3.02% | −40.94% | −48.05% |
| SANION.ST | Saniona AB (publ) | 11.83 SEK | −15.32% | −43.93% | −12.37% |
| BINV.ST | BioInvent International AB (publ) | 24.30 SEK | +5.42% | −17.21% | −23.46% |
| CRNO-B.ST | Cereno Scientific AB (publ) | 4.71 SEK | +0.13% | −32.04% | −53.59% |
| BICO.ST | BICO Group AB (publ) | 19.92 SEK | +36.25% | −1.19% | −17.00% |
| GENO.ST | Genovis AB (publ.) | 20.15 SEK | +2.81% | −7.36% | −16.91% |
| PAX.ST | Paxman AB (publ) | 57.50 SEK | +26.37% | +2.68% | −21.45% |
| SEDANA.ST | Sedana Medical AB (publ) | 12.02 SEK | +23.92% | +12.13% | −22.05% |
| MVIR.ST | Medivir AB (publ) | 2.08 SEK | +14.29% | +351.19% | +4.73% |
| CRAD-B.ST | C-Rad AB (publ) | 35.30 SEK | −4.08% | +11.00% | +6.49% |
| HAMLET-B.ST | Hamlet BioPharma AB (publ) | 6.10 SEK | −17.57% | +7.02% | −0.81% |
| SYNACT.ST | SynAct Pharma AB | 19.66 SEK | +12.99% | −12.43% | +10.82% |
| DVYSR.ST | Devyser Diagnostics AB (publ) | 59.70 SEK | −12.97% | −47.45% | −60.78% |
| NANOFS.ST | Nanoform Finland Oyj | 10.94 SEK | +15.40% | −15.06% | +19.56% |
| IBT-B.ST | Infant Bacterial Therapeutics AB (publ) | 68.60 SEK | +3.94% | +37.75% | +15.88% |
| NANEXA.ST | Nanexa AB (publ) | 4.63 SEK | +14.46% | +15.03% | +100.43% |
| EQL.ST | EQL Pharma AB (publ) | 27.05 SEK | +34.58% | −54.31% | −67.01% |
| ALZCUR.ST | AlzeCure Pharma AB (publ) | 6.40 SEK | +4.23% | +220.80% | +78.27% |
| DICOT.ST | Dicot Pharma AB | 0.21 SEK | +13.89% | −32.06% | −76.06% |
| CINPHA.ST | Cinclus Pharma Holding AB (publ) | 13.70 SEK | +13.41% | −28.65% | −11.27% |
| ONCO.ST | Oncopeptides AB (publ) | 1.65 SEK | +2.93% | −66.11% | −67.92% |
| SEZI.ST | Senzime AB (publ) | 3.78 SEK | +3.28% | −30.35% | −39.98% |
| EPIS-B.ST | Episurf Medical AB (publ) | 0.08 SEK | +37.70% | +90.12% | +71.52% |
| MOB.ST | Moberg Pharma AB (publ) | 10.70 SEK | +9.52% | +4.49% | +32.92% |
| FLUO.ST | FluoGuide A/S | 33.40 SEK | +6.71% | −9.49% | −18.34% |
| BACTI-B.ST | Bactiguard Holding AB (publ) | 14.35 SEK | −8.89% | −24.47% | −46.25% |
| XSPRAY.ST | Xspray Pharma AB (publ) | 10.74 SEK | −35.77% | −64.61% | −76.00% |
| CANTA.ST | Cantargia AB (publ) | 1.91 SEK | +3.24% | −53.64% | −27.38% |
| ORX.ST | Orexo AB (publ) | 13.54 SEK | −5.71% | −58.27% | −35.06% |
| IMMU.ST | Mendus AB (publ) | 7.10 SEK | +2.60% | +23.05% | −4.57% |
| CLBIO.ST | Corline Biomedical AB | 18.85 SEK | +6.80% | +8.96% | +45.56% |
| OSSD.ST | OssDsign AB (publ) | 4.00 SEK | −10.01% | −64.60% | −73.26% |
| ENZY.ST | Enzymatica AB (publ) | 1.90 SEK | +4.97% | −1.04% | −20.17% |
| MNTC.ST | Mentice AB (publ) | 12.75 SEK | −13.85% | −4.85% | −6.59% |
| IVACC.ST | Intervacc AB (publ) | 1.10 SEK | −14.11% | +17.98% | +4.78% |
| ORT-B.ST | Ortoma AB (publ) | 7.80 SEK | −13.24% | −42.22% | −66.52% |
| QLINEA.ST | Q-linea AB (publ) | 18.70 SEK | +8.41% | −35.52% | −62.97% |
| SPRINT.ST | Sprint Bioscience AB (publ) | 3.15 SEK | −15.32% | +111.41% | +458.51% |
| BIOWKS.ST | Bio-Works Technologies AB (publ) | 3.31 SEK | −10.78% | +14.53% | +4.75% |
| BRAIN.ST | BrainCool AB (publ) | 0.73 SEK | −1.22% | +21.87% | −21.51% |
| ACARIX.ST | Acarix AB (publ) | 0.24 SEK | −3.99% | −10.93% | −14.11% |
| IRLAB-A.ST | IRLAB Therapeutics AB (publ) | 1.75 SEK | +32.27% | −13.13% | −44.31% |
| ISOFOL.ST | Isofol Medical AB (publ) | 0.84 SEK | +5.79% | +12.60% | −1.87% |
| KLAR.ST | Klaria Pharma Holding AB (publ.) | 1.05 SEK | +32.58% | +50.57% | +97.38% |
| INTEG-B.ST | Integrum AB (publ) | 8.66 SEK | −0.92% | −16.73% | −79.55% |
| SCIB.ST | SciBase Holding AB (publ) | 20.40 SEK | −34.19% | −18.40% | −29.25% |
| DEX.ST | Dextech Medical AB | 10.30 SEK | −0.96% | +11.35% | +26.38% |
| XBRANE.ST | Xbrane Biopharma AB (publ) | 9.36 SEK | −6.40% | −9.77% | −72.31% |
| ORTI-A.ST | Ortivus AB (publ) | 2.00 SEK | +6.38% | +52.67% | −35.48% |
| ELIC.ST | Elicera Therapeutics AB (publ) | 2.70 SEK | +13.71% | −47.97% | −61.50% |
| ALZ.ST | Alzinova AB (publ) | 0.84 SEK | −13.70% | +0.48% | −39.02% |
| ABERA.ST | Abera Bioscience AB | 8.18 SEK | −2.62% | +13.61% | +1.61% |
| SENZA.ST | SenzaGen AB | 5.10 SEK | −3.41% | −15.00% | −17.48% |
| INIT.ST | Initiator Pharma A/S | 2.47 SEK | +9.78% | −18.75% | −27.35% |
| HEART.ST | Scandinavian Real Heart AB (Publ) | 18.70 SEK | −3.86% | +34.05% | +3.31% |
| DMYD-B.ST | Diamyd Medical AB (publ) | 1.03 SEK | −0.39% | −91.17% | −90.97% |
| PRO.ST | Promimic AB (publ) | 8.50 SEK | −18.27% | −44.98% | −41.38% |
| XINT.ST | Xintela AB (publ) | 0.18 SEK | −8.31% | −37.88% | −51.08% |
| ORTI-B.ST | Ortivus AB (publ) | 1.62 SEK | −13.83% | +32.79% | +42.11% |
| ACTI.ST | Active Biotech AB (publ) | 5.50 SEK | +6.38% | +19.57% | −62.00% |
| NICA.ST | Nanologica AB (publ) | 0.44 SEK | −3.30% | −41.33% | −69.86% |
| PTRK.ST | Physitrack PLC | 8.06 SEK | −0.49% | −38.71% | −57.58% |
| BIOVIC-B.ST | Biovica International AB (publ) | 0.45 SEK | −9.46% | +4.41% | −30.12% |
| IZAFE-B.ST | iZafe Group AB (publ) | 0.31 SEK | 0.00% | −33.26% | −17.57% |
| SIMRIS-B.ST | Simris Group AB (PUBL) | 0.10 SEK | −23.09% | +125.34% | −28.35% |
| ACUC.ST | AcuCort AB (publ) | 0.55 SEK | −13.44% | −13.44% | −5.94% |
| NOSA.ST | Nosa Plugs AB | 0.47 SEK | −5.81% | −18.83% | −35.62% |
| BOUL.ST | Boule Diagnostics AB (publ) | 3.19 SEK | −12.36% | −39.58% | −47.36% |
| ICO.ST | Iconovo AB (publ) | 1.26 SEK | +26.00% | +12.50% | −52.09% |
| NXTCL.ST | NextCell Pharma AB | 1.12 SEK | +4.69% | +58.97% | −5.10% |
| ARCOMA.ST | Arcoma AB | 8.26 SEK | +2.74% | +14.72% | −2.13% |
| VIVE.ST | Vivesto AB | 8.90 SEK | +3.01% | −21.10% | −57.13% |
| ONCOZ.ST | OncoZenge AB (publ) | 5.68 SEK | −15.85% | −13.81% | −14.59% |
| ANNX.ST | Annexin Pharmaceuticals AB (publ) | 13.60 SEK | +7.09% | −31.66% | −46.03% |
| CMOTEC-B.ST | Scandinavian ChemoTech AB | 3.05 SEK | −4.69% | −33.84% | −19.74% |
| IMMNOV.ST | Immunovia AB (publ) | 0.15 SEK | −15.58% | −33.66% | −70.74% |
| BIBB.ST | BiBBInstruments AB | 0.59 SEK | −14.70% | −83.74% | −84.94% |
| IDLDX.ST | IDL Diagnostics AB (publ) | 0.41 SEK | −3.28% | +19.36% | −2.36% |
| SPAGO.ST | Spago Nanomedical AB (publ) | 0.12 SEK | +1.32% | +4.55% | −54.00% |
| CLS-B.ST | Clinical Laserthermia Systems AB (publ) | 1.86 SEK | −3.83% | −72.67% | −75.86% |
| ACE.ST | Ascelia Pharma AB (publ) | 0.61 SEK | +16.48% | −81.26% | −88.08% |
| NEWBRY.ST | Newbury Pharmaceuticals AB (publ) | 2.57 SEK | −6.55% | +110.66% | −0.39% |
| PILA.ST | Pila Pharma AB (publ) | 1.68 SEK | +45.45% | −17.24% | −15.41% |
| ERMA.ST | Enorama Pharma AB (publ) | 0.89 SEK | +193.73% | −55.16% | −67.04% |
| CHOSA.ST | Chosa Oncology AB | 0.73 SEK | −14.15% | −20.00% | −9.00% |
| SYNT.ST | SyntheticMR AB (publ) | 0.72 SEK | +24.14% | −46.07% | −74.29% |
| ACOU.ST | AcouSort AB (publ) | 2.77 SEK | −23.48% | −14.77% | −18.29% |
| MODTX.ST | Modus Therapeutics Holding AB (publ) | 0.37 SEK | +0.54% | +19.35% | −85.49% |
| PEXA-B.ST | PExA AB (publ) | 0.34 SEK | −31.80% | +48.26% | +79.47% |
| QLIFE.ST | Qlife Holding AB (publ) | 1.81 SEK | −6.91% | −30.80% | −52.47% |
| NEOLA.ST | Neola Medical AB (publ) | 0.49 SEK | −17.67% | −54.05% | −79.24% |
| REDS.ST | Redsense Medical AB (publ) | 3.23 SEK | −19.05% | −24.71% | −39.96% |
| BIOSGN.ST | Biosergen AB (publ) | 2.48 SEK | +262.31% | −93.80% | −94.62% |
| ODI.ST | ODI Pharma AB (publ) | 2.20 SEK | −5.17% | −48.36% | +39.24% |
| SDOS.ST | ScandiDos AB (publ) | 0.86 SEK | +3.61% | −25.22% | −34.85% |
| SERV.ST | Servana AB | 0.01 SEK | −16.22% | +210.00% | +106.67% |
| FLUI.ST | Fluicell AB (publ) | 34.60 SEK | +14.57% | +246.00% | +247.74% |
| KONT.ST | Kontigo Care AB (publ) | 1.33 SEK | −8.62% | −26.39% | −42.39% |
| AINO.ST | Aino Health AB (publ) | 0.20 SEK | +2.06% | +3.66% | −10.81% |
| DBP-B.ST | Double Bond Pharmaceutical International AB (publ) | 0.16 SEK | +30.42% | +16.79% | +11.79% |
| PMED.ST | PEPTONIC medical AB (publ) | 0.00 SEK | +20.00% | −25.00% | −25.00% |
| EXPRS2.ST | ExpreS2ion Biotech Holding AB (publ) | 1.38 SEK | −0.36% | −91.79% | −93.99% |
| SPERM.ST | Spermosens AB (publ) | 0.01 SEK | −10.20% | +57.14% | +15.79% |
| GUARD.ST | Disruptive Pharma AB (publ) | 1.47 SEK | −10.49% | +1.94% | −93.53% |
| PROGEN.ST | Prostatype Genomics AB (publ) | 0.16 SEK | −4.59% | −59.48% | −79.42% |
| PERP-B.ST | Perpetua Medical AB (publ) | 3.04 SEK | −18.50% | −41.54% | −35.32% |
| ZENI.ST | Zenicor Medical Systems AB (publ) | 0.97 SEK | +1.58% | −13.06% | −59.79% |
| SPEC.ST | SpectraCure AB (publ) | 0.03 SEK | −3.33% | −79.63% | −81.77% |
| POLAR.ST | PolarCool AB (publ) | 1.73 SEK | +8.12% | −55.87% | −67.96% |
| GABA.ST | Gabather AB (publ) | 0.03 SEK | +10.00% | +6.94% | −17.20% |
| VSD-B.ST | Vibrosense Dynamics AB (publ) | 0.70 SEK | +16.33% | −27.14% | −58.08% |
| PHAL.ST | PharmaLundensis AB | 0.32 SEK | 0.00% | +8.19% | +37.83% |
| RESP.ST | Respiratorius AB (publ) | 2.28 SEK | +3.17% | +31.03% | −39.20% |
| ATORX.ST | Alligator Bioscience AB (publ) | 0.03 SEK | −32.46% | −91.74% | −99.27% |
| IMS.ST | Invent Medic Sweden AB (publ) | 0.10 SEK | +6.95% | −69.51% | −22.48% |
| APTA.ST | Aptahem AB (publ) | 0.56 SEK | −15.96% | −51.69% | −67.65% |
| MONI.ST | Monivent AB | 0.17 SEK | −5.71% | −49.39% | −37.02% |
| NANECH.ST | NanoEcho AB (publ) | 0.03 SEK | −3.51% | −57.96% | −72.03% |
| 2CUREX.ST | 2cureX AB (publ) | 0.66 SEK | −62.67% | +22.68% | −71.79% |
| ODIN.ST | Odinwell AB (publ) | 0.14 SEK | −25.80% | −50.71% | −61.25% |
| LXB.ST | Luxbright AB (publ) | 0.06 SEK | −42.86% | −88.33% | −91.76% |
| MAGLE.ST | Magle Chemoswed Holding AB (publ) | 0.40 SEK | −25.93% | −97.66% | −98.15% |
| ISAB.ST | Inhalation Sciences Sweden AB (publ) | 0.14 SEK | −35.19% | −70.34% | −73.58% |
| S2M.ST | S2Medical AB (publ) | 0.00 SEK | −11.11% | −52.00% | −63.08% |
| NIDHOG.ST | Nidhogg Resources Holding AB (publ) | 0.47 SEK | +16.75% | −41.99% | −72.69% |
| SDET.ST | SensoDetect Aktiebolag (publ) | 0.00 SEK | −27.27% | −97.75% | −99.53% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.